Status:

COMPLETED

Consequences of Doing What Should Not be Done in Primary Care

Lead Sponsor:

Universidad Miguel Hernandez de Elche

Collaborating Sponsors:

Osasunbidea

Servicio Madrileño de Salud, Madrid, Spain

Conditions:

Overdose

Adverse Event

Eligibility:

All Genders

Brief Summary

Retrospective observational study in a random selection of 5% of digital records active between 2014 and 2017 to quantify the frequency of Do not do primary care recommendations, calculating the over-...

Detailed Description

Basement: Overuse subjected patients to unnecessary risk without promoting a sufficient clinical benefit and over-cost. The Less is More Medicine movement has led to the identification of Do not do in...

Eligibility Criteria

Inclusion

  • All patients visiting GPs

Exclusion

  • None

Key Trial Info

Start Date :

October 14 2018

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

February 10 2020

Estimated Enrollment :

750000 Patients enrolled

Trial Details

Trial ID

NCT03482232

Start Date

October 14 2018

End Date

February 10 2020

Last Update

April 3 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

FISABIO

Elche, Alicante, Spain, 03202

2

Universidad Miguel Hernández

Elche, Alicante, Spain, 03202